Biological functions of protein disulfide isomerase as a target of phenolic endocrine-disrupting chemicals

Journal of Health Science

Volumn 56, Issue 1, 2010, Pages 1-13

  Okada, Kazushi ^a   Hashimoto, Shoko ^a   Imaoka, Susumu ^a  

^a KWANSEI GAKUIN UNIVERSITY   (Japan)

Author keywords

Bisphenol A; Chaperone; Endocrine disrupting chemical; Protein disulfide isomerase; Protein folding; Thyroid hormone

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; POLYCHLORINATED BIPHENYL; PROTEIN DISULFIDE ISOMERASE;

BIOLOGICAL ACTIVITY; BIOLOGY; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME STRUCTURE; HUMAN; HYPOPHYSIS CELL; NONHUMAN; OXIDATION; PROTEIN FAMILY; PROTEIN FOLDING; REVIEW;

RATTUS;

EID: 76249112068     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.56.1     Document Type: Review

References (130)

1. Colborn, T. (2004) Neurodevelopment and endocrine disruption. Environ. Health Perspect., 112, 944-949.
2. Miyagawa, K., Narita, M., Akama, H. and Suzuki, T. (2007) Memory impairment associated with a dysfunction of the hippocampal cholinergic system induced by prenatal and neonatal exposures to bisphenol-A. Neurosci. Lett., 418, 236-241.
3. Narita, M., Miyagawa, K., Mizuo, K., Yoshida, T. and Suzuki, T. (2007) Changes in central dopaminergic systems and morphine reward by prenatal and neonatal exposure to bisphenol-A in mice: evidence for the importance of exposure period. Addict. Biol., 12, 167-172.
4. Tando, S., Itoh, K., Yaoi, T., Ikeda, J., Fujiwara, Y. and Fushiki, S. (2007) Effects of pre- and neonatal exposure to bisphenol A on murine brain development. Brain Dev., 29, 352-356.
5. Suzuki, T., Mizuo, K., Nakazawa, H., Funae, Y., Fushiki, S., Fukushima, S., Shirai, T. and Narita, M. (2003) Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neuroscience, 117, 639-644.
6. Krishnan, A. V., Stathis, P., Permuth, S. F., Tokes, L. and Feldman, D. (1993) Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology, 132, 2279-2286.
7. Brotons, J. A., Olea-Serrano, M. F., Villalobos, M., Pedraza, V. and Olea, N. (1995) Xenoestrogens released from lacquer coatings in food cans. Environ. Health Perspect., 103, 608-612.
8. Olea, N., Pulgar, R., Perez, P., Olea-Serrano, F., Rivas, A., Novillo-Fertrell, A., Pedraza, V., Soto, A. M. and Sonnenschein, C. (1996) Estrogenicity of resin-based composites and sealants used in dentistry. Environ. Health Perspect., 104, 298-305.
9. Howdeshell, K. L., Hotchkiss, A. K., Thayer, K. A., Vandenbergh, J. G. and vom Saal, F. S. (1999) Exposure to bisphenol A advances puberty. Nature, 401, 763-764.
10. Kubo, K., Arai, O., Ogata, R., Omura, M., Hori, T. and Aou, S. (2001) Exposure to bisphenol A during the fetal and suckling periods disrupts sexual differentiation of the locus coeruleus and of behavior in the rat. Neurosci. Lett., 304, 73-76.
11. Markey, C. M., Luque, E. H., Munoz De Toro, M., Sonnenschein, C. and Soto, A. M. (2001) In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol. Reprod., 65, 1215-1223.
12. Nagel, S. C., vom Saal, F. S., Thayer, K. A., Dhar, M. G., Boechler, M. and Welshons, W. V. (1997) Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect., 105, 70-76.
13. Schonfelder, G., Flick, B., Mayr, E., Talsness, C., Paul, M. and Chahoud, I. (2002) In utero exposure to low doses of bisphenol A lead to long-term deleterious effects in the vagina. Neoplasia, 4, 98-102.
14. Vom Saal, F. S., Cooke, P. S., Buchanan, D. L., Palanza, P., Thayer, K. A., Nagel, S. C., Parmigiani, S. and Welshons, W. V. (1998) A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol. Ind. Health, 14, 239-260.
15. Welshons, W. V., Nagel, S. C., Thayer, K. A., Judy, B. M. and vom Saal, F. S. (1999) Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice. Toxicol. Ind. Health, 15, 12-25.
16. Kabuto, H., Amakawa, M. and Shishibori, T. (2004) Exposure to bisphenol A during embryonic/fetal life and infancy increases oxidative injury and causes underdevelopment of the brain and testis in mice. Life Sci., 74, 2931-2940.
17. Kawai, K., Nozaki, T., Nishikata, H., Aou, S., Takii, M. and Kubo, C. (2003) Aggressive behavior and serum testosterone concentration during the maturation process of male mice: the effects of fetal exposure to bisphenol A. Environ. Health Perspect., 111, 175-178.
18. Palanza, P. L., Howdeshell, K. L., Parmigiani, S. and vom Saal, F. S. (2002) Exposure to a low dose of bisphenol A during fetal life or in adulthood alters maternal behavior in mice. Environ. Health Perspect., 110 Suppl. 3, 415-422.
19. Baba, K., Okada, K., Kinoshita, T. and Imaoka, S. (2009) Bisphenol A disrupts Notch signaling by inhibiting gamma-secretase activity and causes eye dysplasia of Xenopus laevis. Toxicol. Sci., 108, 344-355.
20. Imaoka, S., Mori, T. and Kinoshita, T. (2007) Bisphenol A causesmalformation of the head region in embryos of Xenopus laevis and decreases the expression of the ESR-1 gene mediated by Notch signaling. Biol. Pharm. Bull., 30, 371-374.
21. Yoneda, T., Hiroi, T., Osada, M., Asada, A. and Funae, Y. (2003) Non-genomic modulation of dopamine release by bisphenol-A in PC12 cells. J. Neurochem., 87, 1499-1508.
22. Tanabe, N., Kimoto, T. and Kawato, S. (2006) Rapid Ca(2+) signaling induced by Bisphenol A in cultured rat hippocampal neurons. Neuro. Endocrinol. Lett., 27, 97-104.
23. Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R. and Snyder, S. H. (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature, 351, 714-718.
24. Garthwaite, J., Charles, S. L. and Chess-Williams, R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature, 336, 385-388.
25. Hiroi, T., Okada, K., Imaoka, S., Osada, M. and Funae, Y. (2006) Bisphenol A binds to protein disulfide isomerase and inhibits its enzymatic and hormone-binding activities. Endocrinology, 147, 2773-2780.
26. Okada, K., Hiroi, T., Imaoka, S. and Funae, Y. (2005) Inhibitory effects of environmental chemicals on protein disulfide isomerase in vitro. Osaka City Med. J., 51, 51-63.
27. 3. Mol. Cell. Endocrinol., 278, 44-51.
28. Goldberger, R. F., Epstein, C. J. and Anfinsen, C. B. (1964) Purification and Properties of a Microsomal Enzyme System Catalyzing the Reactivation of Reduced Ribonuclease and Lysozyme. J. Biol. Chem., 239, 1406-1410.
29. Lyles, M. M. and Gilbert, H. F. (1991) Catalysis of the oxidative folding of ribonuclease A by protein disulfide isomerase: dependence of the rate on the composition of the redox buffer. Biochemistry, 30, 613-619.
30. Laboissiere, M. C., Sturley, S. L. and Raines, R. T. (1995) The essential function of protein-disulfide isomerase is to unscramble non-native disulfide bonds. J. Biol. Chem., 270, 28006-28009.
31. Bulleid, N. J. and Freedman, R. B. (1988) Defective co-translational formation of disulphide bonds in protein disulphide-isomerase-deficient microsomes. Nature, 335, 649-651.
32. Wilkinson, B. and Gilbert, H. F. (2004) Protein disulfide isomerase. Biochim. Biophys. Acta, 1699, 35-44.
33. Turano, C., Coppari, S., Altieri, F. and Ferraro, A. (2002) Proteins of the PDI family: unpredicted non-ER locations and functions. J. Cell. Physiol., 193, 154-163.
34. Koivu, J., Myllyla, R., Helaakoski, T., Pihlajaniemi, T., Tasanen, K. and Kivirikko, K. I. (1987) A single polypeptide acts both as the beta subunit of prolyl 4-hydroxylase and as a protein disulfide-isomerase. J. Biol. Chem., 262, 6447-6449.
35. Tasanen, K., Parkkonen, T., Chow, L. T., Kivirikko, K. I. and Pihlajaniemi, T. (1988) Characterization of the human gene for a polypeptide that acts both as the beta subunit of prolyl 4-hydroxylase and as protein disulfide isomerase. J. Biol. Chem., 263, 16218-16224.
36. Wetterau, J. R., Aggerbeck, L. P., Laplaud, P. M. and McLean, L. R. (1991) Structural properties of the microsomal triglyceride-transfer protein complex. Biochemistry, 30, 4406-4412.
37. Wetterau, J. R., Combs, K. A., McLean, L. R., Spinner, S. N. and Aggerbeck, L. P. (1991) Protein disulfide isomerase appears necessary to maintain the catalytically active structure of the microsomal triglyceride transfer protein. Biochemistry, 30, 9728-9735.
38. Wetterau, J. R., Combs, K. A., Spinner, S. N. and Joiner, B. J. (1990) Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex. J. Biol. Chem., 265, 9800-9807.
39. Myllyharju, J. and Kivirikko, K. I. (2004) Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet., 20, 33-43.
40. Vuori, K., Pihlajaniemi, T., Marttila, M. and Kivirikko, K. I. (1992) Characterization of the human prolyl 4-hydroxylase tetramer and its multifunctional protein disulfide-isomerase subunit synthesized in a baculovirus expression system. Proc. Natl. Acad. Sci. U.S.A., 89, 7467-7470.
41. Vuori, K., Pihlajaniemi, T., Myllyla, R. and Kivirikko, K. I. (1992) Site-directed mutagenesis of human protein disulphide isomerase: effect on the assembly, activity and endoplasmic reticulum retention of human prolyl 4-hydroxylase in Spodoptera frugiperda insect cells. EMBO J., 11, 4213-4217.
42. Wetterau, J. R. and Zilversmit, D. B. (1985) Purifi-cation and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes. Chem. Phys. Lipids, 38, 205-222.
43. Guthapfel, R., Gueguen, P. and Quemeneur, E. (1996) Reexamination of hormone-binding properties of protein disulfide-isomerase. Eur. J. Biochem., 242, 315-319.
44. Horiuchi, R., Yamauchi, K., Hayashi, H., Koya, S., Takeuchi, Y., Kato, K., Kobayashi, M. and Takikawa, H. (1989) Purification and characterization of 55-kDa protein with 3,5,3′-triiodo-L-thyronine-binding activity and protein disulfideisomerase activity from beef liver membrane. Eur. J. Biochem., 183, 529-538.
45. Noiva, R. (1999) Protein disulfide isomerase: the multifunctional redox chaperone of the endoplasmic reticulum. Semin. Cell Dev. Biol., 10, 481-493.
46. Primm, T. P. and Gilbert, H. F. (2001) Hormone binding by protein disulfide isomerase, a high capacity hormone reservoir of the endoplasmic reticulum. J. Biol. Chem., 276, 281-286.
47. Cheng, S. Y. (1983) Structural similarities in the plasma membrane 3,3′,5-triiodo-L-thyronine receptors fromhuman, rat andmouse cultured cells. Analysis by affinity labeling. Endocrinology, 113, 1155-1157.
48. Horiuchi, R., Johnson, M. L., Willingham, M. C., Pastan, I. and Cheng, S. (1982) Affinity labeling of the plasma membrane 3,3′,5-triiodo-L- thyronine receptor in GH3 cells. Proc. Natl. Acad. Sci. U.S.A., 79, 5527-5531.
49. Cheng, S. Y., Hasumura, S., Willingham, M. C. and Pastan, I. (1986) Purification and characterization of a membrane-associated 3,3′,5-triiodo- L-thyronine binding protein from a human carcinoma cell line. Proc. Natl. Acad. Sci. U.S.A., 83, 947-951.
50. Hasumura, S., Kitagawa, S., Lovelace, E., Willingham, M. C., Pastan, I. and Cheng, S. (1986) Characterization of a membrane-associated 3,3′,5-triiodo-L-thyronine binding protein by use of monoclonal antibodies. Biochemistry, 25, 7881-7888.
51. Cheng, S. Y., Gong, Q. H., Parkison, C., Robinson, E. A., Appella, E., Merlino, G. T. and Pastan, I. (1987) The nucleotide sequence of a human cellular thyroid hormone binding protein present in endoplasmic reticulum. J. Biol. Chem., 262, 11221-11227.
52. Yamauchi, K., Yamamoto, T., Hayashi, H., Koya, S., Takikawa, H., Toyoshima, K. and Horiuchi, R. (1987) Sequence of membrane-associated thyroid hormone binding protein from bovine liver: its identity with protein disulphide isomerase. Biochem. Biophys. Res. Commun., 146, 1485-1492.
53. Kimura, H., Noiva, R., Mizunaga, T., Yamauchi, K., Horiuchi, R., Cheng, S. Y. and Lennarz, W. J. (1990) Thyroid hormone binding protein contains glycosylation site binding protein activity. Biochem. Biophys. Res. Commun., 170, 1319-1324.
54. Tsibris, J. C., Hunt, L. T., Ballejo, G., Barker, W. C., Toney, L. J. and Spellacy, W. N. (1989) Selective inhibition of protein disulfide isomerase by estrogens. J. Biol. Chem., 264, 13967-13970.
55. Freedman, R. B., Gane, P. J., Hawkins, H. C., Hlodan, R., McLaughlin, S. H. and Parry, J. W. (1998) Experimental and theoretical analyses of the domain architecture of mammalian protein disulphide-isomerase. Biol. Chem., 379, 321-328.
56. Pirneskoski, A., Klappa, P., Lobell, M., Williamson, R. A., Byrne, L., Alanen, H. I., Salo, K. E., Kivirikko, K. I., Freedman, R. B. and Ruddock, L. W. (2004) Molecular characterization of the principal substrate binding site of the ubiquitous folding catalyst protein disulfide isomerase. J. Biol. Chem., 279, 10374-10381.
57. Tian, G., Xiang, S., Noiva, R., Lennarz, W. J. and Schindelin, H. (2006) The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites. Cell, 124, 61-73.
58. Munro, S. and Pelham, H. R. (1987) A C-terminal signal prevents secretion of luminal ER proteins. Cell, 48, 899-907.
59. Klappa, P., Ruddock, L. W., Darby, N. J. and Freedman, R. B. (1998) The b' domain provides the principal peptide-binding site of protein disulfide isomerase but all domains contribute to binding of misfolded proteins. EMBO J., 17, 927-935.
60. Darby, N. J., Penka, E. and Vincentelli, R. (1998) The multi-domain structure of protein disulfide isomerase is essential for high catalytic efficiency. J. Mol. Biol., 276, 239-247.
61. Nguyen, V. D., Wallis, K., Howard, M. J., Haapalainen, A. M., Salo, K. E., Saaranen, M. J., Sidhu, A., Wierenga, R. K., Freedman, R. B., Ruddock, L. W. and Williamson, R. A. (2008) Alternative conformations of the x region of human protein disulphide-isomerase modulate exposure of the substrate binding b' domain. J. Mol. Biol., 383, 1144-1155.
62. Denisov, A. Y., Maattanen, P., Dabrowski, C., Kozlov, G., Thomas, D. Y. and Gehring, K. (2009) Solution structure of the bb' domains of human protein disulfide isomerase. FEBS J., 276, 1440-1449.
63. Freedman, R. B., Hirst, T. R. and Tuite, M. F. (1994) Protein disulphide isomerase: building bridges in protein folding. Trends Biochem. Sci., 19, 331-336.
64. Tian, R., Li, S. J., Wang, D. L., Zhao, Z., Liu, Y. and He, R. Q. (2004) The acidic C-terminal domain stabilizes the chaperone function of protein disulfide isomerase. J. Biol. Chem., 279, 48830-48835.
65. Kulp, M. S., Frickel, E. M., Ellgaard, L. and Weissman, J. S. (2006) Domain architecture of protein-disulfide isomerase facilitates its dual role as an oxidase and an isomerase in Ero1p-mediated disulfide formation. J. Biol. Chem., 281, 876-884.
66. Creighton, T. E. (1997) Protein folding coupled to disulphide bond formation. Biol. Chem., 378, 731-744.
67. Ruddon, R. W. and Bedows, E. (1997) Assisted protein folding. J. Biol. Chem., 272, 3125-3128.
68. Van Anken, E. and Braakman, I. (2005) Versatility of the endoplasmic reticulum protein folding factory. Crit. Rev. Biochem. Mol. Biol., 40, 191-228.
69. Freedman, R. B., Bulleid, N. J., Hawkins, H. C. and Paver, J. L. (1989) Role of protein disulphide-isomerase in the expression of native proteins. Biochem. Soc. Symp., 55, 167-192.
70. Primm, T. P., Walker, K. W. and Gilbert, H. F. (1996) Facilitated protein aggregation. Effects of calcium on the chaperone and anti-chaperone activity of protein disulfide-isomerase. J. Biol. Chem., 271, 33664-33669.
71. Hashimoto, S., Okada, K. and Imaoka, S. (2008) Interaction between bisphenol derivatives and protein disulphide isomerase (PDI) and inhibition of PDI functions: requirement of chemical structure for binding to PDI. J. Biochem. (Tokyo), 144, 335-342.
72. Mizunaga, T., Katakura, Y., Miura, T. and Maruyama, Y. (1990) Purification and characterization of yeast protein disulfide isomerase. J. Biochem. (Tokyo), 108, 846-851.
73. Watanabe, I., Kashimoto, T. and Tatsukawa, R. (1983) Identification of the flame retardant tetrabromobisphenol-A in the river sediment and the mussel collected in Osaka. Bull. Environ. Contam. Toxicol., 31, 48-52.
74. White, R., Jobling, S., Hoare, S. A., Sumpter, J. P. and Parker, M. G. (1994) Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology, 135, 175-182.
75. Puhakka, J. A. and Jarvinen, K. (1992) Aerobic Fluidized-Bed Treatment of Polychlorinated Phenolic Wood Preservative Constituents. Water Res., 26, 765-770.
76. Fent, K. (1996) Ecotoxicology of organotin compounds. Crit. Rev. Toxicol., 26, 3-117.
77. Harino, H., Ohji, M., Wattayakorn, G., Adulyanukosol, K., Arai, T. and Miyazaki, N. (2007) Accumulation of organotin compounds in tissues and organs of stranded whales along the coasts of Thailand. Arch. Environ. Contam. Toxicol., 53, 119-125.
78. Strand, J., Larsen, M. M. and Lockyer, C. (2005) Accumulation of organotin compounds and mercury in harbour porpoises (Phocoena phocoena) from the Danish waters and West Greenland. Sci. Total Environ., 350, 59-71.
79. Kannan, K., Senthilkumar, K. and Giesy, J. P. (1999) Occurrence of butyltin compounds in human blood. Environ. Sci. Technol., 33, 1776-1779.
80. Giam, C. S., Chan, H. S., Neff, G. S. and Atlas, E. L. (1978) Phthalate ester plasticizers: a new class of marine pollutant. Science, 199, 419-421.
81. Page, B. D. and Lacroix, G. M. (1995) The occurrence of phthalate ester and di-2-ethylhexyl adipate plasticizers in Canadian packaging and food sampled in 1985-1989: a survey. Food Addit. Contam., 12, 129-151.
82. Sharman, M., Read, W. A., Castle, L. and Gilbert, J. (1994) Levels of di-(2-ethylhexyl)phthalate and total phthalate esters in milk, cream, butter and cheese. Food Addit. Contam., 11, 375-385.
83. Shibko, S. I. and Blumenthal, H. (1973) Toxicology of phthalic acid esters used in food-packaging material. Environ. Health Perspect., 3, 131-137.
84. Jacobson, J. L. and Jacobson, S. W. (1996) Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N. Engl. J. Med., 335, 783-789.
85. Jacobson, J. L. and Jacobson, S. W. (1997) Evidence for PCBs as neurodevelopmental toxicants in humans. Neurotoxicology, 18, 415-424.
86. Jacobson, J. L., Jacobson, S. W. and Humphrey, H. E. (1990) Effects of exposure to PCBs and related compounds on growth and activity in children. Neurotoxicol. Teratol., 12, 319-326.
87. Jacobson, S. W., Fein, G. G., Jacobson, J. L., Schwartz, P. M. and Dowler, J. K. (1985) The effect of intrauterine PCB exposure on visual recognition memory. Child Dev., 56, 853-860.
88. Kato, Y., Ikushiro, S., Takiguchi, R., Haraguchi, K., Koga, N., Uchida, S., Sakaki, T., Yamada, S., Kanno, J. and Degawa, M. (2007) A novel mechanism for polychlorinated biphenyl-induced decrease in serum thyroxine level in rats. Drug Metab. Dispos., 35, 1949-1955.
89. Porterfield, S. P. (1994) Vulnerability of the developing brain to thyroid abnormalities: environmental insults to the thyroid system. Environ. Health Perspect., 102 Suppl. 2, 125-130.
90. Porterfield, S. P. and Hendry, L. B. (1998) Impact of PCBs on thyroid hormone directed brain development. Toxicol. Ind. Health, 14, 103-120.
91. Tilson, H. A., Jacobson, J. L. and Rogan, W. J. (1990) Polychlorinated biphenyls and the developing nervous system: cross-species comparisons. Neurotoxicol. Teratol., 12, 239-248.
92. Bergman, A., Klasson-Wehler, E. and Kuroki, H. (1994) Selective retention of hydroxylated PCB metabolites in blood. Environ. Health Perspect., 102, 464-469.
93. Sandau, C. D., Ayotte, P., Dewailly, E., Duffe, J. and Norstrom, R. J. (2000) Analysis of hydroxylated metabolites of PCBs (OH-PCBs) and other chlorinated phenolic compounds in whole blood from Canadian inuit. Environ. Health Perspect., 108, 611-616.
94. Hovander, L., Malmberg, T., Athanasiadou, M., Athanassiadis, I., Rahm, S., Bergman, A. and Wehler, E. K. (2002) Identification of hydroxylated PCB metabolites and other phenolic halogenated pollutants in human blood plasma. Arch. Environ. Contam. Toxicol., 42, 105-117.
95. Haraguchi, K., Hirose, Y., Masuda, Y., Kato, Y. and Kimura, R. (1999) Metabolism of 3,3′,4,4′,5-penta- and 2,2′,3,3′,4, 4′-hexachlorobiphenyls in rats. Fukuoka Igaku Zasshi, 90, 210-219 (in Japanese).
96. Yang, F., Xu, Y., Pan, H. and Wu, D. (2008) Induction of hepatic cytochrome P4501A1/2B activity and disruption of thyroglobulin synthesis/secretion by mono-ortho polychlorinated biphenyl and its hydroxylated metabolites in rat cell lines. Environ. Toxicol. Chem., 27, 220-225.
97. Daidoji, T., Gozu, K., Iwano, H., Inoue, H. and Yokota, H. (2005) UDP-glucuronosyltransferase isoforms catalyzing glucuronidation of hydroxypolychlorinated biphenyls in rat. Drug Metab. Dispos., 33, 1466-1476.
98. Liu, Y., Apak, T. I., Lehmler, H. J., Robertson, L. W. and Duffel, M. W. (2006) Hydroxylated polychlorinated biphenyls are substrates and inhibitors of human hydroxysteroid sulfotransferase SULT2A1. Chem. Res. Toxicol., 19, 1420-1425.
99. Okada, K., Hashimoto, S., Funae, Y. and Imaoka, S. (2009) Hydroxylated polychlorinated biphenyls (PCBs) interact with protein disulfide isomerase and inhibit its activity. Chem. Res. Toxicol., 22, 899-904.
100. Hohenwarter, O., Waltenberger, A. and Katinger, H. (1996) An in vitro test system for thyroid hormone action. Anal. Biochem., 234, 56-59.
101. Samuels, H. H., Forman, B. M., Horowitz, Z. D. and Ye, Z. S. (1989) Regulation of gene expression by thyroid hormone. Annu. Rev. Physiol., 51, 623-639.
102. Edman, J. C., Ellis, L., Blacher, R. W., Roth, R. A. and Rutter, W. J. (1985) Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature, 317, 267-270.
103. Pihlajaniemi, T., Helaakoski, T., Tasanen, K., Myllyla, R., Huhtala, M. L., Koivu, J. and Kivirikko, K. I. (1987) Molecular cloning of the beta-subunit of human prolyl 4-hydroxylase. This subunit and protein disulphide isomerase are products of the same gene. EMBO J., 6, 643-649.
104. Obata, T., Kitagawa, S., Gong, Q. H., Pastan, I. and Cheng, S. Y. (1988) Thyroid hormone downregulates p55, a thyroid hormone-binding protein that is homologous to protein disulfide isomerase and the beta-subunit of prolyl-4-hydroxylase. J. Biol. Chem., 263, 782-785.
105. Freedman, R. B., Klappa, P. and Ruddock, L. W. (2002) Protein disulfide isomerases exploit synergy between catalytic and specific binding domains. EMBO Rep., 3, 136-140.
106. Anelli, T., Alessio, M., Mezghrani, A., Simmen, T., Talamo, F., Bachi, A. and Sitia, R. (2002) ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family. EMBO J., 21, 835-844.
107. Ferrari, D. M., Nguyen Van, P., Kratzin, H. D. and Soling, H. D. (1998) ERp28, a human endoplasmic-reticulum-lumenal protein, is a member of the protein disulfide isomerase family but lacks a CXXC thioredoxin-box motif. Eur. J. Biochem., 255, 570-579.
108. Cunnea, P. M., Miranda-Vizuete, A., Bertoli, G., Simmen, T., Damdimopoulos, A. E., Hermann, S., Leinonen, S., Huikko, M. P., Gustafsson, J. A., Sitia, R. and Spyrou, G. (2003) ERdj5, an endoplasmic reticulum (ER)-resident protein containing DnaJ and thioredoxin domains, is expressed in secretory cells or following ER stress. J. Biol. Chem., 278, 1059-1066.
109. Alanen, H. I., Williamson, R. A., Howard, M. J., Lappi, A. K., Jantti, H. P., Rautio, S. M., Kellokumpu, S. and Ruddock, L. W. (2003) Functional characterization of ERp18, a new endoplasmic reticulum-located thioredoxin superfamily member. J. Biol. Chem., 278, 28912-28920.
110. Kemmink, J., Darby, N. J., Dijkstra, K., Nilges, M. and Creighton, T. E. (1997) The folding catalyst protein disulfide isomerase is constructed of active and inactive thioredoxin modules. Curr. Biol., 7, 239-245.
111. Oliver, J. D., van der Wal, F. J., Bulleid, N. J. and High, S. (1997) Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science, 275, 86-88.
112. Zapun, A., Darby, N. J., Tessier, D. C., Michalak, M., Bergeron, J. J. and Thomas, D. Y. (1998) Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57. J. Biol. Chem., 273, 6009-6012.
113. Mazzarella, R. A., Srinivasan, M., Haugejorden, S. M. and Green, M. (1990) ERp72, an abundant luminal endoplasmic reticulum protein, contains three copies of the active site sequences of protein disulfide isomerase. J. Biol. Chem., 265, 1094-1101.
114. Hwang, Y. S., Seo, J. J., Cha, S. W., Lee, H. S., Lee, S. Y., Roh, D. H., Kung, H. F., Kim, J. and Ja Park, M. (2002) Antimorphic PV.1 causes secondary axis by inducing ectopic organizer. Biochem. Biophys. Res. Commun., 292, 1081-1086.
115. Tanaka, S., Uehara, T. and Nomura, Y. (2000) Upregulation of protein-disulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. J. Biol. Chem., 275, 10388-10393.
116. Conn, K. J., Gao, W., McKee, A., Lan, M. S., Ullman, M. D., Eisenhauer, P. B., Fine, R. E. and Wells, J. M. (2004) Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Res., 1022, 164-172.
117. Uehara, T., Nakamura, T., Yao, D., Shi, Z. Q., Gu, Z., Ma, Y., Masliah, E., Nomura, Y. and Lipton, S. A. (2006) S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature, 441, 513-517.
118. Kim, H. T., Russell, R. L., Raina, A. K., Harris, P. L., Siedlak, S. L., Zhu, X., Petersen, R. B., Shimohama, S., Smith, M. A. and Perry, G. (2000) Protein disulfide isomerase in Alzheimer disease. Antioxid. Redox Signal., 2, 485-489.
119. Yoo, B. C., Krapfenbauer, K., Cairns, N., Belay, G., Bajo, M. and Lubec, G. (2002) Overexpressed protein disulfide isomerase in brains of patients with sporadic Creutzfeldt-Jakob disease. Neurosci. Lett., 334, 196-200.
120. Safran, M. and Leonard, J. L. (1991) Characterization of a N-bromoacetyl-L-thyroxine affinity-labeled 55-kilodalton protein as protein disulfide isomerase in cultured glial cells. Endocrinology, 129, 2011-2016.
121. Delom, F., Mallet, B., Carayon, P. and Lejeune, P. J. (2001) Role of extracellular molecular chaperones in the folding of oxidized proteins. Refolding of colloidal thyroglobulin by protein disulfide isomerase and immunoglobulin heavy chain-binding protein. J. Biol. Chem., 276, 21337-21342.
122. Liu, X. W. and Sok, D. E. (2004) Multimerization of bovine thyroglobulin, partially unfolded or partially unfolded/reduced; involvement of protein disulfide isomerase and glutathionylated disulfide linkage. Arch. Pharm. Res., 27, 1275-1283.
123. Couet, J., de Bernard, S., Loosfelt, H., Saunier, B., Milgrom, E. and Misrahi, M. (1996) Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain. Biochemistry, 35, 14800-14805.
124. Brent, G. A. (1994) The Molecular-Basis of Thyroid-Hormone Action. N. Engl. J. Med., 331, 847-853.
125. Anderson, G. W. (2001) Thyroid hormones and the brain. Front. Neuroendocrinol., 22, 1-17.
126. Vaccari, A. (1988) Teratogenic Mechanisms of Dysthyroidism in the Central Nervous System. Prog. Brain Res., 73, 71-86.
127. Nunez, J. (1984) Effects of Thyroid-Hormones during Brain Differentiation. Mol. Cell. Endocrinol., 37, 125-132.
128. Akaike, M., Kato, N., Ohno, H. and Kobayashi, T. (1991) Hyperactivity and Spatial Maze-Learning Impairment of Adult-Rats with Temporary Neonatal-Hypothyroidism. Neurotoxicol. Teratol., 13, 317-322.
129. Stein, S. A., Adams, P. M., Shanklin, D. R., Mihailoff, G. A. and Palnitkar, M. B. (1991) Thyroid hormone control of brain and motor development: molecular, neuroanatomical, and behavioral studies. Adv. Exp. Med. Biol., 299, 47-105.
130. Goldey, E. S., Kehn, L. S., Rehnberg, G. L. and Crofton, K. M. (1995) Effects of developmental hypothyroidism on auditory and motor function in the rat. Toxicol. Appl. Pharmacol., 135, 67-76.